fact sheet template (portrait) | metro south health · web view2019 metro south hhs - research...
TRANSCRIPT
Centres for Health Research
2019 Metro South HHS - Research Support Scheme
INNOVATION (SEED) SMALL GRANTS APPLICATION FORM
Applications Close 5pm, 20 August 2018
All Research Support Grant applications are required to demonstrate enhanced cross disciplinary collaborations across Metro South HHS (e.g. across medical, allied health, nursing departments, and basic/clinical research). Research proposals must demonstrate potential for the research to be translated into improved health outcomes.
INNOVATION (SEED) SMALL GRANTS provide $25,000 support over two years of funding for research projects that propose genuinely new work and are not currently or previously funded from any source. Eligibility is open to all MSH researchers
PART A: INSTRUCTIONS AND GENERAL ELIGIBILITY CHECK
1. APPLICATION INSTRUCTIONS
Refer to the Research Support Scheme 2019 Funding Guidelines when preparing your application:
https://metrosouth.health.qld.gov.au/sites/default/files/content/2019-rss-funding-guidelines.pdf
All sections of the form must be completed
The Applicant is required to sign the application on behalf of the research team
2. SUBMISSION
Applications must be submitted electronically to [email protected]
A signed copy of the application to be submitted as a PDF (electronic signatures accepted)
The application must also be submitted in Word format (signatures not required)
Save your application file using the following naming convention: Applicant Surname_2019 Innovation
3. DUE DATE
Applications must be received electronically by the Centres for Health Research
Applications are due no later than 5.00pm Monday 20 August 2018
Late or incomplete applications may not be accepted
4. ENQUIRIES TO: The Centres for Health Research
Metro South Hospital and Health Service
Email: [email protected] Phone: 07 3443 8057
5. APPLICANT ELIGIBILITY CRITERIA
To be eligible for a 2019 Research Support Grant the Applicant must be able to answer:
Yes to questions 1-5
No to question 6
Yes No
1 Are you a member of staff of MSH (Honorary Appointees are not eligible)?
2 Will your appointment be for the duration of the grant?
3 Will the majority (more than 50%) of the research activity take place on a MSH campus?
4 Does the research demonstrate cross disciplinary collaborations? Select the disciplines involved:
Medical ☐Allied Health ☐Nursing ☐Basic / Clinical Research ☐
5 Are all the Co-Investigators
a) a member of staff of MSH with an appointment for the duration of the grant OR
b) a member of staff of a Metro South Health academic partner university school or research institute based on a Metro South Health campus
6 Is the proposed research activity currently funded through an award type currently listed on the Australian Competitive Grants Register or international equivalent?
https://www.education.gov.au/news/2018-australian-competitive-grants-register-acgr-now-available
6. APPLICANT APPOINTMENT DETAILSProvide details of your MSH and/or academic partner university appointment(s) (maximum ¼ of an A4 page) E.g.: Occupational Therapist at PA Hospital; MSH provides UQ with 50% of my salary; QUT Postgraduate Candidate based at IHBI in the Translational Research InstituteNOTE: N/A (or similar) will not be accepted
7. LOCATION OF RESEARCH ACTIVITYProvide details of where the majority (more than 50%) of the research activity will take place (maximum ¼ of an A4 page)
V3.0 Effective: June 2018 Review: January 2019Page 2 of 20
PART B: GRANT APPLICATION FORM
2019 METRO SOUTH HHS - Research Support Scheme
INNOVATION (SEED) SMALL GRANT
1. PROJECT TITLE
(Maximum 200 characters including spaces)
2. INVESTIGATIVE TEAM
The Applicant must be the PI (Principal Investigator).
The maximum number of: Co-Investigators (CIs) = 4; Associate Investigators (AIs) = 2
Title Name Health profession
Organisation MSH FractionEg: 0.5 FTE or none
PI Click to choose
First name Surname Click to choose Click to choose
CI1 Click to choose
First name Surname Click to choose Click to choose
CI2 Click to choose
First name Surname Click to choose Click to choose
CI3 Click to choose
First name Surname Click to choose Click to choose
CI4 Click to choose
First name Surname Click to choose Click to choose
AI1 Click to choose
First name Surname Click to choose Type name here
AI2 Click to choose
First name Surname Click to choose Type name here
V3.0 Effective: June 2018 Review: January 2019Page 3 of 20
3. ASSESSMENT OF PROJECT APPLICATIONS WILL BE AGAINST THE CRITERION LISTED BELOW:
Assessment of Project Applications will be against the criterion listed below:
# Evaluation Criteria for Innovation (Seed) Small Grants
Percent Weighting
Scoring system of each criteria
1 Significance and capacity to lead change in practice or service delivery
20% From 1 to 7 where:
1. = No evidence
2. = Unsatisfactory
3. = Fair
4. = Good
5. = Very Good
6. = Excellent
7. = Outstanding
2 Quality of Research Plan 20%
3 Strength of the Interdisciplinary collaboration and ability of the team to build research capacity
20%
4 Feasibility of the project and likelihood of meeting objectives within the stated time
15%
5 Novelty of the proposed project 15%
6 Justification of the budget 10%
3.1 ASSESSMENT CRITERIA 1: SIGNIFICANCE AND CAPACITY TO LEAD CHANGE IN PRACTICE OR SERVICE DELIVERY
Assessment of the significance of the proposed research will be on the basis of:
Burden of disease
Translation Impact
Innovation.
3.1.1 BURDEN OF DISEASE
Describe how this project will address and reduce the burden of disease addressed in your proposal (no more than ¾ of an A4 page)
V3.0 Effective: June 2018 Review: January 2019Page 4 of 20
3.1.2 TRANSLATIONAL ASPECT OF THE RESEARCH PROPOSAL
What is the translational aspect of your project? (Select one box)
T0 – Identification of opportunities and approaches to a health problem (basic research)
T1 – Findings from basic research tested for clinical effect and/or applicability (Phase I and II clinical trials; observational studies)
T2 – Health application to evidence based practice guidelines (Phase III clinical trials; observational studies; evidence synthesis and guidelines development)
T3 – Practice guidelines to health practices (dissemination research; implementation research; diffusion research; Phase IV clinical trials)
T4 – Practice to population health (outcomes research; population monitoring of morbidity, mortality, benefits and risk studies)
Not applicable
Definitions taken from UC San Diego Clinical and Translational Research Institute
3.1.3 CLINICAL SIGNIFICANCE
Why is this research clinically significant ? (Maximum of ½ an A4 page)
3.2 ASSESSMENT CRITERIA 2: QUALITY OF THE RESEARCH PLAN
3.2.1 RESEARCH PROPOSAL SUMMARYProvide your research proposal on the following pages. Include Applicant’s name, Title of project, Hypothesis, Expected outcomes, Background, Research protocol and references.
Assessment of the scientific quality of the research will be based on:
Definition of project (based on clear articulation of the Hypothesis, Background, Expected outcomes)
Study Design (Based on Methods, Research Protocol)
Feasibility (including assessment of Methods and Budget)
Insert your Research Proposal in the box below (You can type directly into the box; cut and paste or insert an embedded PDF. See Instructions – inserting text)
V3.0 Effective: June 2018 Review: January 2019Page 5 of 20
INSTRUCTIONS
Research Proposal Format
Maximum 4 pages including references
Arial font with a minimum size of 10 point (including tables, table legends and figure legends)
Line spacing of 1.5 lines
Top and bottom page margins of 2 cm
Left and right page margins of 2 cm
Inserting text
Type directly into the text box above, maintaining format as described above; or
Cut and paste (e.g. from a previous document) into the text box – note you may lose formatting if you choose this option; or
Embed a PDF document (displayed as an icon) of your complete proposal, maintaining formatting as described below.
- Prepare your Research Proposal as per the format instructions above - Save your Research Proposal as a PDF document- Place Cursor in the box above- Select “Insert” tab on MSWord Toolbar- Select “Object” and choose “Create from File” from drop down- Browse for your PDF document- Select Insert- Select “Display as Icon”- Click OK- An icon of your Research Proposal content should be displayed in the box above.
3.3 ASSESSMENT CRITERIA 3: STRENGTH OF THE INTERDISCIPLINARY COLLABORATION AND ABILITY OF THE TEAM TO BUILD CAPACITY IN RESEARCH
3.3.1 DESCRIBE THE COLLABORATIVE AND INTERDISCIPLINARY STRENGTHS OF THE PROJECT (less than ½ an A4 page)
3.3.2 PRINCIPAL INVESTIGATOR (PI) (APPLICANT)
PI CONTACT DETAILS
Applicant name Click to choose First Name Surname
Position
Organisational department Department Name
Phone number(s) Primary: Secondary:
Email address
V3.0 Effective: June 2018 Review: January 2019Page 6 of 20
P1 ACADEMIC QUALIFICATIONS & APPOINTMENTS
Academic QualificationsEg: MBBS:
Academic AppointmentsEg: Senior Lecturer, XXDept, UQ :
PI RESEARCH TIME
Expected 2019 time allocation to: This study (hr/wk): Other studies (hr/wk):
Do you expect to have an extended period of absence during 2019? Yes No
If Yes, provide expected dates DD/MM/YEAR - DD/MM/YEAR
Reason(¼ A4 page or less)
PI PUBLICATIONS
List your publications produced in the last 5 years which have the most relevance to the study proposed in this application with ALL authors provided) Press <Enter> after each publication to maintain the numbering system
1.
PI GRANTSProvide details of research funding received in the last 5 years and indicate whether the funding relates to the proposed research of this application. If more than 8 please eliminate least applicable to this research proposal.
Funding body and type Start dateEnd date
Amount Relevant to this application?
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY] $ Yes
V3.0 Effective: June 2018 Review: January 2019Page 7 of 20
Funding body and type Start dateEnd date
Amount Relevant to this application?
[DD/MM/YYYY] No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
[DD/MM/YYYY]
[DD/MM/YYYY]
$ Yes
No
PI RESEARCH PERFORMANCE RELEVANT TO OPPORTUNITY
Are there any disruptions to your career (greater than 28 calendar days) that may have impacted on your research performance that you would like to have taken into consideration?
Please outline in the section below in ¼ A4 page or less.
1.
V3.0 Effective: June 2018 Review: January 2019Page 8 of 20
3.3.3 CO-INVESTIGATOR 1 (CI1)
CI1 CONTACT DETAILS
CI1 name Click to choose First Name Surname
Position
MSH site Click to choose
Organisational department Department Name
Phone number
Email address
CI1 ACADEMIC QUALIFICATIONS & APPOINTMENTS
Academic QualificationsEg: MBBS:
Academic AppointmentsEg: Senior Lecturer, XX Dept, UQ :
CI1 RESEARCH TIME
Expected 2019 time allocation to: This study (hr/wk): Other studies (hr/wk):
Does CI1 expect to have an extended period of absence during 2019? Yes No
If Yes, provide expected dates DD/MM/YEAR - DD/MM/YEAR
Reason(¼ A4 page or less)
CI1 PUBLICATIONS
List publications produced in the last 5 years which have the most relevance to the study proposed in this application with ALL authors provided
Press <Enter> after each publication to maintain the numbering system
1.
V3.0 Effective: June 2018 Review: January 2019Page 9 of 20
3.3.4 CO-INVESTIGATOR 2 (CI2)
CI2 CONTACT DETAILS
CI2 name Click to choose First Name Surname
Position
MSH site Click to choose
Organisational department Department Name
Phone number
Email address
CI2 ACADEMIC QUALIFICATIONS & APPOINTMENTS
Academic QualificationsEg: MBBS:
Academic AppointmentsEg: Senior Lecturer, XX Dept, UQ :
CI2 RESEARCH TIME
Expected 2019 time allocation to: This study (hr/wk): Other studies (hr/wk):
Does CI2 expect to have an extended period of absence during 2019? Yes No
If Yes, provide expected dates DD/MM/YEAR - DD/MM/YEAR
Reason(¼ A4 page or less)
CI2 PUBLICATIONS
List publications produced in the last 5 years which have the most relevance to the study proposed in this application with ALL authors provided
Press <Enter> after each publication to maintain the numbering system
1.
V3.0 Effective: June 2018 Review: January 2019Page 10 of 20
3.3.5 CO-INVESTIGATOR 3 (CI3)
CI3 CONTACT DETAILS
CI3 name Click to choose First Name Surname
Position
MSH site Click to choose
Organisational department Department Name
Phone number
Email address
CI3 ACADEMIC APPOINTMENTS
Academic QualificationsEg: MBBS:
Academic AppointmentsEg: Senior Lecturer, XX Dept, UQ :
CI3 RESEARCH TIME
Expected 2019 time allocation to: This study (hr/wk): Other studies (hr/wk):
Does CI3 expect to have an extended period of absence during 2019? Yes No
If Yes, provide expected dates DD/MM/YEAR - DD/MM/YEAR
Reason(¼ A4 page or less)
CI3 PUBLICATIONS
List publications produced in the last 5 years which have the most relevance to the study proposed in this application with ALL authors provided
Press <Enter> after each publication to maintain the numbering system
1.
V3.0 Effective: June 2018 Review: January 2019Page 11 of 20
3.3.6 CO-INVESTIGATOR 4 (CI4)
CI4 CONTACT DETAILS
CI4 name Click to choose First Name Surname
Position
MSH site Click to choose
Organisational department Department Name
Phone number
Email address
CI4 ACADEMIC APPOINTMENTS
Academic QualificationsEg: MBBS:
Academic AppointmentsEg: Senior Lecturer, XX Dept, UQ :
CI4 RESEARCH TIME
Expected 2019 time allocation to: This study (hr/wk): Other studies (hr/wk):
Does CI4 expect to have an extended period of absence during 2019? Yes No
If Yes, provide expected dates DD/MM/YEAR - DD/MM/YEAR
Reason(¼ A4 page or less)
CI4 PUBLICATIONS
List publications produced in the last 5 years which have the most relevance to the study proposed in this application with ALL authors provided
Press <Enter> after each publication to maintain the numbering system
1.
V3.0 Effective: June 2018 Review: January 2019Page 12 of 20
3.3.7 ASSOCIATE INVESTIGATOR 1Outline the role of AI1 in the broad research plan proposed in this application and indicate why AI1 has been included within the research team (no more than ½ an A4 page)
3.3.7 ASSOCIATE INVESTIGATOR 2
Outline the role of AI2 in the broad research plan proposed in this application and indicate why AI2 has been included within the research team (no more than ½ an A4 page)
3.3.8 OTHER SUBMITTED GRANT APPLICATIONS
Provide details of grant applications related to this study submitted to other funding bodies in the current year
Funding body and type Project title Budget
$
$
$
$
$
$
V3.0 Effective: June 2018 Review: January 2019Page 14 of 20
3.4 ASSESSMENT CRITERIA 4: FEASIBILITY OF THE PROJECT AND LIKELIHOOD OF MEETING OBJECTIVES WITHIN THE STATED TIME
3.4.1 PROJECT TIMELINE AND KEY DELIVERABLES
Outline the project timeline with key deliverables or expected outcomes (copy and paste rows as required)
Date or Time period Key Deliverables
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
Click here to enter text. Click here to enter text.
3.4.2 TRANSLATION OF FINDINGS OF THIS INNOVATION PROJECT
Outline how you plan to translate the findings of this project and where relevant how you will translate the findings to other practice areas or services. (No more than ½ an A4 page)
3.5 ASSESSMENT CRITERIA 5: NOVELTY OF THE PROPOSED INNOVATION PROJECT
3.5.1 What makes this Innovation Grant Application Novel or Innovative? (Less than ½ an A4 page)
V3.0 Effective: June 2018 Review: January 2019Page 15 of 20
3.6 ASSESSMENT CRITERIA 6: BUDGET
3.6.1 BUDGET PROPOSAL
List all items individually (hit enter in the field to add additional lines)N.B. Funds must be expended within 2 years
BUDGET CATEGORIES AMOUNT REQUESTED
Personnel
i. include type of appointment and on-costs
ii. include the facility institution where this person will undertake the majority of the research
iii. include whether this person is a MSH staff member
Total
Equipment
i. List items costing more than $500 each
ii. Indicate whether they will be procured through MSH
Total
Maintenance / Consumables
i. Include equipment items costing $500 or less each
ii. Identify whether these items will be procured through MSH
Total
Travel / Conferences
Total
Otheri. Note: Computers will not be funded
ii. May also include Biostatistics services; Clinical Research Facility Costs; Biorepository costs; Legal Costs for
Intellectual Property Considerations; Pharmacy; Pathology; X-ray costs.
Total
GRAND TOTAL
Budget justification
V3.0 Effective: June 2018 Review: January 2019Page 16 of 20
Click here to enter text.
3.7 NAMES OF EXTERNAL EXPERTS
Applicants must nominated three experts who may be called upon to provide expert opinion on your grant application (they will not be the sole reviewers as in previous years)
For nominations to be eligible the Applicant must be able to answer Yes to all questions
Yes No
1 Are all three nominated experts external to MSH and the university school(s)/research institute(s) of all named investigators?
2 Is at least one nominated expert from interstate or overseas?
3 Are all three nominated experts an acknowledged expert in the field of the proposed research (i.e. publication track record, PhD or equivalent research experience)?
4 Are all three nominated experts completely independent of the investigative team (including AIs) and without conflict of interest? (See section 7.4.1 of the 2019 Funding Guidelines)
5 Have all three nominated experts agreed to be available from September to October 2018 to provide expert advice to the MSH Review Panel? Please ensure you advise the expert of the name of the PI on this grant as all correspondence with the experts will be linked to the PI name
Note: A breach of the above may disadvantage your application
3.7.1 EXTERNAL EXPERT 1
Name Click to choose First Name Surname
Health profession Click to choose
Organisation/Institution Organisation/Institution Name
Department Department Name
Phone number: Email:
Availability confirmed? Yes No
Comments (¼ A4 page or less)
Who contacted this expert?
V3.0 Effective: June 2018 Review: January 2019Page 17 of 20
3.7.2 EXTERNAL EXPERT 2
Name Click to choose First Name Surname
Health profession Click to choose
Organisation/Institution Organisation/Institution Name
Department Department Name
Phone number: Email:
Availability confirmed? Yes No
Comments (¼ A4 page or less)
Who contacted this expert?
3.7.3 EXTERNAL EXPERT 3Name Click to choose First Name Surname
Health profession Click to choose
Organisation/Institution Organisation/Institution Name
Department Department Name
Phone number: Email:
Availability confirmed? Yes No
Comments (¼ A4 page or less)
Who contacted this expert?
3.7.4 EXCLUDED EXPERTS
If relevant, list details of up to two experts you would like excluded from providing expert opinion on your application and provide justification for their exclusion
EXCLUDED EXPERT 1
Name Click to choose First Name Surname
Health profession Click to choose
Organisation/Institution Organisation/Institution Name
Department Department Name
Justification Provide details
EXCLUDED EXPERT 2
Name Click to choose First Name Surname
Health profession Click to choose
Organisation/Institution Organisation/Institution Name
Department Department Name
Justification Provide details
V3.0 Effective: June 2018 Review: January 2019Page 18 of 20
4. AGREEMENTS AND CERTIFICATION OF SUPPORT
CERTIFICATION BY THE PRINCIPAL INVESTIGATOR
Please carefully read each of the criteria and ensure the application complies. Marking each box indicates your certification of each criterion. Incomplete applications may be deemed ineligible.
I certify that:
Written agreement (such as an email) has been obtained from all investigators named in this Research Support application and that all details provided are correct.
I understand that should this application be successful, all named Co-Investigators on this application will be required to sign the Acceptance of Offer.
On behalf of the investigative team, we accept and agree to comply with the ethical standards as set out by the National Health and Medical Research Council, and any additional standards required by the appropriate Human Research/Animal Ethics Committee (including, but not limited to the National Statement on Ethical Conduct in Human Research and Australian Code for the Responsible Conduct of Research).
Research will not commence until all ethical clearances and site specific approvals (SSAs), if required, have been obtained.
I acknowledge and accept that grant payments from SERTA can only be made to a Metro South Health (MSH) employee, and must be deposited into a MSH research cost centre.
The research team meets the relevant eligibility criteria for the Metro South Health Research Support Scheme and all mandatory questions have been answered.
Progress reports (Ethics and Projects) must be provided annually and / or a final report must be provided at the end of the support period
On behalf of the investigative team, we accept and agree to comply with Metro South Health. Policies and Procedures and requests from the Centres for Health Research – Metro South Health in the management of these grants.
Name of Principal Investigator (print): SignatureDigital signatures will be accepted
DD/MM/YEAR
Date:
V3.0 Effective: June 2018 Review: January 2019Page 19 of 20
5 CERTIFICATION BY HEAD OF DIVISION/DEPARTMENT
I certify that:
The proposed research is appropriate to the general facilities in my Division/Department and that I am prepared to have the project carried out in my Division/Department.
Experiments involving humans/animals (will) conform to the general principles set out in the National Health and Medical Research Committee’s National Statement on Ethical Conduct in Human Research/Australian Code of Practice for the Care and Use of Animals for Scientific Purposes
Name of Head of Department (print): Signature
Digital signatures will be accepted
DD/MM/YEARDate:
Name of MSH site/university school:
Note: If the Head of Department is also the Principal Investigator then he / she cannot provide certification.
V3.0 Effective: June 2018 Review: January 2019Page 20 of 20